Kotzerke, J.; Buesser, D.; Naumann, A.; Runge, R.; Huebinger, L.; Kliewer, A.; Freudenberg, R.; Brogsitter, C.
Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy. Cancers 2022, 14, 2513.
https://doi.org/10.3390/cancers14102513
AMA Style
Kotzerke J, Buesser D, Naumann A, Runge R, Huebinger L, Kliewer A, Freudenberg R, Brogsitter C.
Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy. Cancers. 2022; 14(10):2513.
https://doi.org/10.3390/cancers14102513
Chicago/Turabian Style
Kotzerke, Joerg, Dorothee Buesser, Anne Naumann, Roswitha Runge, Lisa Huebinger, Andrea Kliewer, Robert Freudenberg, and Claudia Brogsitter.
2022. "Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy" Cancers 14, no. 10: 2513.
https://doi.org/10.3390/cancers14102513
APA Style
Kotzerke, J., Buesser, D., Naumann, A., Runge, R., Huebinger, L., Kliewer, A., Freudenberg, R., & Brogsitter, C.
(2022). Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy. Cancers, 14(10), 2513.
https://doi.org/10.3390/cancers14102513